Patients with schizophrenia not only suffer from severe psychological symptoms, but also have a dramatically increased risk of cardiometabolic diseases. The interplay of disease-associated mechanisms, genetic predispositions and exogenous influences leads to the development of a metabolic syndrome in many patients, which significantly increases morbidity and mortality.
You May Also Like
- Prostate cancer
Diagnosis without drama – ESMO 2025 under the banner of differentiated patient management
- Pneumococcal conjugate vaccine (PCV)
Best possible serotype coverage in the respective age group
- Psoriasis: intervening in the inflammatory cascade
Advantages of early biologic therapy and oral peptide as a beacon of hope
- AI-supported imaging and new biomarkers
CHD diagnostics update
- Bipolar disorder, anxiety disorder, depression
Lurasidone as monotherapy for bipolar I depression with anxiety symptoms
- Arterial hypertension: ESC guideline 2024 in focus
New category “elevated blood pressure” – what are the therapeutic implications?
- Low-grade pediatric gliomas
Consideration of the tumor microenvironment opens up new treatment options
- Palliative care symptom and needs assessment.